Opportunities and challenges of self-binding directives: A comparison of empirical research with stakeholders in three European countries.

Advance statement Ulysses arrangement crisis plan psychiatric advance directive self-binding directive

Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
09 Jun 2023
Historique:
medline: 26 6 2023
pubmed: 9 6 2023
entrez: 9 6 2023
Statut: epublish

Résumé

Self-binding directives (SBDs) are psychiatric advance directives that include a clause in which mental health service users consent in advance to involuntary hospital admission and treatment under specified conditions. Medical ethicists and legal scholars identified various potential benefits of SBDs but have also raised ethical concerns. Until recently, little was known about the views of stakeholders on the opportunities and challenges of SBDs. This article aims to foster an international exchange on SBDs by comparing recent empirical findings on stakeholders' views on the opportunities and challenges of SBDs from Germany, the Netherlands, and the United Kingdom. Comparisons between the empirical findings were drawn using a structured expert consensus process. Findings converged on many points. Perceived opportunities of SBDs include promotion of autonomy, avoidance of personally defined harms, early intervention, reduction of admission duration, improvement of the therapeutic relationship, involvement of persons of trust, avoidance of involuntary hospital admission, addressing trauma, destigmatization of involuntary treatment, increase of professionals' confidence, and relief for proxy decision-makers. Perceived challenges include lack of awareness and knowledge, lack of support, undue influence, inaccessibility during crisis, lack of cross-agency coordination, problems of interpretation, difficulties in capacity assessment, restricted therapeutic flexibility, scarce resources, disappointment due to noncompliance, and outdated content. Stakeholders tended to focus on practical challenges and did not often raise fundamental ethical concerns. Stakeholders tend to see the implementation of SBDs as ethically desirable, provided that the associated challenges are addressed.

Sections du résumé

BACKGROUND BACKGROUND
Self-binding directives (SBDs) are psychiatric advance directives that include a clause in which mental health service users consent in advance to involuntary hospital admission and treatment under specified conditions. Medical ethicists and legal scholars identified various potential benefits of SBDs but have also raised ethical concerns. Until recently, little was known about the views of stakeholders on the opportunities and challenges of SBDs.
AIMS OBJECTIVE
This article aims to foster an international exchange on SBDs by comparing recent empirical findings on stakeholders' views on the opportunities and challenges of SBDs from Germany, the Netherlands, and the United Kingdom.
METHOD METHODS
Comparisons between the empirical findings were drawn using a structured expert consensus process.
RESULTS RESULTS
Findings converged on many points. Perceived opportunities of SBDs include promotion of autonomy, avoidance of personally defined harms, early intervention, reduction of admission duration, improvement of the therapeutic relationship, involvement of persons of trust, avoidance of involuntary hospital admission, addressing trauma, destigmatization of involuntary treatment, increase of professionals' confidence, and relief for proxy decision-makers. Perceived challenges include lack of awareness and knowledge, lack of support, undue influence, inaccessibility during crisis, lack of cross-agency coordination, problems of interpretation, difficulties in capacity assessment, restricted therapeutic flexibility, scarce resources, disappointment due to noncompliance, and outdated content. Stakeholders tended to focus on practical challenges and did not often raise fundamental ethical concerns.
CONCLUSIONS CONCLUSIONS
Stakeholders tend to see the implementation of SBDs as ethically desirable, provided that the associated challenges are addressed.

Identifiants

pubmed: 37293987
doi: 10.1192/j.eurpsy.2023.2421
pii: S0924933823024215
pmc: PMC10305757
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e48

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203376/Z/16/Z
Pays : United Kingdom

Références

Lancet Psychiatry. 2021 Jul;8(7):599-609
pubmed: 34022972
Harv Civ Rights-Civil Lib Law Rev. 1982 Winter;16(3):777-854
pubmed: 11659391
Wellcome Open Res. 2019 Jan 29;4:16
pubmed: 31080892
Yale J Health Policy Law Ethics. 2014 Winter;14(1):1-65
pubmed: 25051651
World Psychiatry. 2023 Jun;22(2):332-333
pubmed: 37159359
Psychiatr Serv. 2023 Apr 1;74(4):381-392
pubmed: 36128696
J Med Ethics. 2001 Apr;27(2):92-7
pubmed: 11314165
Adm Policy Ment Health. 2013 May;40(3):232-9
pubmed: 22240937
Int J Law Psychiatry. 2021 May-Jun;76:101699
pubmed: 33864988
Psychiatr Serv. 2008 Jan;59(1):63-71
pubmed: 18182541
Int J Law Psychiatry. 2020 Jul - Aug;71:101563
pubmed: 32768120
Int J Law Psychiatry. 2012 Jan-Feb;35(1):11-8
pubmed: 22142895
BJPsych Open. 2019 Jun 13;5(4):e53
pubmed: 31530302
Hastings Cent Rep. 1984 Jun;14(3):13-6
pubmed: 6746269
Int J Soc Psychiatry. 2018 Dec;64(8):737-744
pubmed: 30370816
J Med Ethics. 2019 Nov;45(11):693-699
pubmed: 31484783
Univ Miami Law Rev. 1996 Oct;51(1):57-95
pubmed: 11660621
J Med Ethics. 2008 Feb;34(2):77-80
pubmed: 18234942
JAMA Psychiatry. 2016 Jul 1;73(7):657-64
pubmed: 27249180
Adm Policy Ment Health. 2006 Jul;33(4):449-60
pubmed: 16237505
Front Psychiatry. 2022 Oct 21;13:974132
pubmed: 36339872
Psychiatr Serv. 2023 Jan 1;74(1):44-55
pubmed: 36039553
J Med Ethics. 2007 Oct;33(10):560-3
pubmed: 17906050
Wellcome Open Res. 2022 Jul 7;7:182
pubmed: 36081756
Eur J Health Law. 2016 Apr;23(2):158-73
pubmed: 27228684
Int J Law Psychiatry. 2015 May-Jun;40:92-101
pubmed: 25939286
Med J Aust. 2020 Mar;212(5):208-211.e1
pubmed: 32049364
Schizophr Bull. 1991;17(1):1-7
pubmed: 2047781
BMC Med Ethics. 2023 Jun 3;24(1):38
pubmed: 37270612
Front Psychiatry. 2020 Oct 16;11:538107
pubmed: 33192654
Front Psychiatry. 2019 Sep 11;10:631
pubmed: 31572233
Health Care Anal. 2014 Jun;22(2):114-42
pubmed: 22773305
J Eval Clin Pract. 2017 Oct;23(5):1038-1044
pubmed: 28960728
Health Policy. 2004 Dec;70(3):291-301
pubmed: 15488996
Int J Ment Health Nurs. 2015 Dec;24(6):554-60
pubmed: 26293649

Auteurs

Matthé Scholten (M)

Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Bochum, Germany.

Simone A Efkemann (SA)

Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr University Bochum, Bochum, Germany.

Mirjam Faissner (M)

Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr University Bochum, Bochum, Germany.

Marleen Finke (M)

Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Bochum, Germany.

Jakov Gather (J)

Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Bochum, Germany.
Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr University Bochum, Bochum, Germany.

Tania Gergel (T)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Astrid Gieselmann (A)

Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Bochum, Germany.
Department of Psychiatry and Psychotherapy, Charité Campus Benjamin Franklin, Berlin, Germany.

Lia van der Ham (L)

Department of Ethics, Law and Humanities, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Georg Juckel (G)

Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr University Bochum, Bochum, Germany.

Laura van Melle (L)

Department of Ethics, Law and Humanities, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
GGZ inGeest, Amsterdam, The Netherlands.

Gareth Owen (G)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Sarah Potthoff (S)

Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Bochum, Germany.

Lucy A Stephenson (LA)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

George Szmukler (G)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Astrid Vellinga (A)

Mentrum/Arkin, Amsterdam, The Netherlands.

Jochen Vollmann (J)

Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Bochum, Germany.

Yolande Voskes (Y)

Department of Ethics, Law and Humanities, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Anna Werning (A)

Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr University Bochum, Bochum, Germany.

Guy Widdershoven (G)

Department of Ethics, Law and Humanities, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH